ClinicalTrials.gg
RecruitingNCT07862777Updated Oct 7, 2026

Geriatric Nutritional Risk Index and ASA Status for Predicting Lung Complications After Major Abdominal Surgery in Older Adults

An observational study in Postoperative Pulmonary Complications (PPC), sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 7, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
170
Ages
65 Years and older
Sex
All
01

Study summary

Postoperative pulmonary complications (PPCs), such as pneumonia, atelectasis, and respiratory failure, are major causes of illness, prolonged hospital stays, and intensive care admissions in older patients undergoing elective major abdominal surgery. The American Society of Anesthesiologists Physical Status (ASA-PS) classification is commonly used before surgery to estimate risk. However, ASA-PS does not directly measure nutritional depletion or muscle weakness, which are critical risk factors in geriatric patients.

The Geriatric Nutritional Risk Index (GNRI) is a simple, objective screening tool calculated from preoperative serum albumin levels and body weight.

The purpose of this observational study is to evaluate the role of GNRI in predicting postoperative pulmonary complications and to determine whether adding GNRI to the standard ASA-PS classification improves the ability to identify older patients at high risk for lung complications after major abdominal surgery.

02

Conditions studied

  • Postoperative Pulmonary Complications (PPC)

Keywords

  • Geriatric Nutritional Risk Index
  • ASA Physical Status
  • Postoperative Pulmonary Complications
  • Elective Major Abdominal Surgery
03

In context

Lead sponsor

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital is the lead sponsor of 76 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adults aged 65 years or older who are scheduled to undergo elective major abdominal surgery under general anesthesia at Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital in Ankara, Turkey. Eligible participants will be enrolled consecutively after informed consent is obtained from the participant or their legal representative. Major procedures may include colorectal surgery, gastrectomy, pancreatic surgery, and major hepatobiliary resection. Patients undergoing emergency or minor surgery, those with active pneumonia or acute respiratory failure before surgery, and those with missing preoperative albumin, weight, or height data will be excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 65 years or older.
  • Scheduled for elective major abdominal surgery under general anesthesia, including colorectal surgery, gastrectomy, pancreatic surgery, or major hepatobiliary resection.
  • Physical Status (ASA-PS) class I, II, III, or IV.
  • provided by the participant or their legal representative.

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery.
  • Minor or superficial procedures that do not require major intra-abdominal surgery, such as diagnostic laparoscopy, simple laparoscopic cholecystectomy, or simple hernia repair.
  • Active pneumonia or acute respiratory failure before surgery.
  • Missing preoperative serum albumin, body weight, or height measurements.
  • Does not provide or withdraws from the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
170 participants (estimated)
Patient registry
No

Groups and cohorts

  • Older Adults Undergoing Elective Major Abdominal Surgery
06

What researchers measure

Primary outcomes

  1. Incidence of Postoperative Pulmonary Complications Within 30 Days

    The proportion of participants who develop at least one postoperative pulmonary complication within 30 days after surgery. Complications, including pneumonia, atelectasis, respiratory failure, or reintubation, will be identified according to the European Perioperative Clinical Outcome (EPCO) consensus definitions using hospital records and the planned 30-day follow-up.

    Time frame: From the date of surgery through postoperative day 30.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared to protect participant confidentiality and comply with institutional and local ethical approval restrictions. Aggregated data and study findings will be available within the published manuscript and supplementary files.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2026 (actual). Primary completion is estimated for Jul 2027, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 7, 2026
StartActual
Oct 2, 2026
Primary completionEst.
Jul 1, 2027
CompletionEst.
Aug 1, 2027
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07862777
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Responsible party
Arif Timuroğlu, MD (anesthesiology specialist, M.D., Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital) — Principal investigator
First posted
Oct 7, 2026
Start date
Oct 2, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

arif timuroglu, MD
Contact
ariftimuroglu@yahoo.com
05072601980
arif timuroglu
principal investigator · Dr. Abdurrahman yurtaslan Ankara Oncology Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion